Huntleigh Advisors Inc. lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 16,810 shares of the healthcare product maker’s stock after acquiring an additional 360 shares during the quarter. Huntleigh Advisors […]

Goelzer Investment Management Inc. lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 4.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,062 shares of the healthcare product maker’s stock after selling 291 shares during the period. Goelzer Investment […]

Tandem Investment Advisors Inc. trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 987,573 shares of the healthcare product maker’s stock after selling 5,025 shares during the quarter. […]

D.A. Davidson & CO. grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 5.7% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 166,676 shares of the healthcare product maker’s stock after buying an additional 8,926 shares during the quarter. […]

Redmont Wealth Advisors LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 260 shares of the healthcare product maker’s stock, valued at approximately $34,000. A number […]

Monument Capital Management grew its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 15.5% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 2,278 shares of the healthcare product maker’s stock after acquiring an additional 306 shares during the period. Monument Capital Management’s holdings in Abbott […]

Almanack Investment Partners LLC. lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,166 shares of the healthcare product maker’s stock after selling 400 shares during the period. […]

KBC Group NV cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 30.9% in the first quarter, Holdings Channel reports. The fund owned 665,075 shares of the healthcare product maker’s stock after selling 297,537 shares during the quarter. KBC Group NV’s holdings in Abbott Laboratories were worth $88,223,000 as of its most recent […]

Highland Capital Management LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 49,398 shares of the healthcare product maker’s stock after selling 242 shares during the quarter. Highland […]

Tsfg LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 103,800 shares of the healthcare product maker’s stock after selling 2,261 shares during the period. Abbott Laboratories comprises 2.8% […]

Westend Capital Management LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 134.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,889 shares of the healthcare product maker’s stock after buying an additional 2,800 shares during the period. Abbott […]

DLK Investment Management LLC lifted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.3% in the first quarter, HoldingsChannel.com reports. The fund owned 50,345 shares of the healthcare product maker’s stock after buying an additional 1,122 shares during the quarter. Abbott Laboratories comprises 2.8% of DLK Investment Management LLC’s portfolio, making the stock […]

Kentucky Retirement Systems cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 118,139 shares of the healthcare product maker’s stock after selling 1,425 shares during the quarter. Kentucky Retirement Systems’ holdings in […]

Hill Island Financial LLC cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 49.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,261 shares of the healthcare product maker’s stock after selling 2,201 shares during the quarter. Hill Island Financial […]